Last reviewed · How we verify
NCT03968510
Swalqol in Primary Hyperparathyroidism
trial testing parathyroidectomy in Hyperparathyroidism in 150 participants. Completed in 1 November 2020.
1 July 2020
Quick facts
| Lead sponsor | Uşak University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 150 |
| Start date | 1 November 2018 |
| Primary completion | 1 July 2020 |
| Estimated completion | 1 November 2020 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- parathyroidectomy
Conditions studied
- Hyperparathyroidism — all drugs for Hyperparathyroidism →
Sponsor
Uşak University
Who can join
Eligibility, any sex, with Hyperparathyroidism. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Swallow related quality of life before and after parathyroidectomy will be evaluated in patients with primary hyperparathyridism.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03968510
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of parathyroidectomy
Trials testing the same drug.
- NCT06913296 — PTeye in Parathyroid Adenoma · recruiting
- NCT06709586 — Thermal Ablation Versus Parathyroidectomy for Secondary Hyperparathyroidism · not yet recruiting
- NCT06779760 — Near Infrared Autofluorescence Imaging in Minimally-Invasive Video-Assisted Parathyroidectomy (NIRAF MIVAP Study) · completed
Other recruiting trials for Hyperparathyroidism
Currently open trials in the same condition.
- NCT07415421 — Parathyroidectomy After Kidney Transplantation · NA · recruiting
- NCT07083557 — Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiome · recruiting
- NCT07010380 — Dual-Channel Near-Infrared Autofluorescence Imaging and AI Analysis to Locate Parathyroid Glands (PTFinder) · recruiting
- NCT06711874 — Abnormally High Parathyroid Hormone Levels Worsens Outcomes in Vitamin D Depleted Critical Care Patients · active not recruiting
- NCT06499142 — STP.168 Clinical Study Protocol Parakeet · NA · active not recruiting
Other Uşak University trials
Trials by the same sponsor.
- NCT07356362 — High-power Laser Therapy for Notalgia Paresthetica. · NA · not yet recruiting
- NCT07328360 — The Efficacy of High-Power Laser Therapy in Meralgia Paresthetica · NA · recruiting
- NCT07276477 — Inspiratory Muscle Training After Stroke · NA · recruiting
- NCT07296380 — Manual Therapy Behavior Scale in Physiotherapists · enrolling by invitation
- NCT07296367 — Physiotherapy and Disaster · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03968510 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Uşak University
- Last refreshed: 4 June 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03968510.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing